From: CircRNAs: versatile players and new targets in organ fibrosis
Organ | Diseases | CircRNA | Dysregulation in disease | Pathophysiological function | Mechanism of action | References |
---|---|---|---|---|---|---|
Heart | Doxorubicin- induced CF | CircNlgn | Upregulated in myocardial tissues of patients with selected congenital heart defects with cardiac overload. | Transgenic mice overexpressing circNlgn impaired cardiac function and induced CF. Silencing circNlgn decreased the effects of doxorubicin on cardiac cell activities and retarded fibrosis. | CircNlgn-derived peptide Nlgn173 could bind and activate H2AX, producing γH2AX, resulting in upregulation of IL-1b, IL-2Rb, IL-6 and EGR1/3. | [45] |
Heart | CF | CircYap | Decreased in patients with cardiac hypertrophy and TAC mice. | Ectopic circYap improved heart function and alleviated fibrosis. | CircYap facilitated the binding of TPM4 with ACTG, resulting in increased inhibitory effect of TPM4 on actin polymerization. | [49] |
Heart | Myocardial fibrosis | CircUbe3a | Elevated in M2M-SEV in heart of acute myocardial injury. | Impaired cardiac function and exacerbated cardiac fibrosis by promoting the proliferation, migration and differentiation. | Targeting miR-138-5p/RhoC signaling pathway. | [52] |
Heart | Cardiac hepatopathy | Circslc8a1 | Decreased in mice TAC heart. | Silencing circslc8a1induces cardiac hypertrophy, fibrosis, and hepatic steatosis, and over-expressing it exerts protective effects. | Interacted with mitochondrial-associated proteins, i.e. ATBP, COX5B, NUDFS2, and facilitate ATP production. | [53] |
Liver | Radiation-induced liver disease | CircRSF1 | Upregulated in irradiated LX2 cells | Promoted the survival and inflammatory as well as fibrotic phenotype of irradiated LX2 cells. | MiR-146a-5p/RAC1 | [57] |
Liver | CCl4-induced HF | CircFBXW4 | Decreased in HF | Overexpression of circFBXW4 inhibited HSC proliferation and activation, induced HSC apoptosis, thereby antagonizing fibrosis. | MiR-18b-3p/FBXW7 | [59] |
Liver | CCl4-induced HF | CircPSD3 | Down-regulated in HF | Inhibited the proliferation and activation of HSC. In vivo overexpression of circPSD3 alleviated hepatic fibrosis. | MiR-92b-3p/smad7 | [60] |
Liver | CCl4-induced HF | CircUbe2k | Elevated in HF. | Enhanced the activation and and prolifereation of HSC in vivo and in vitro. | MiR-149-5p/TGF-β2 | [65] |
Liver | NASH | CircSCAR | Decreased in HSC from NASH patients. | Inhibits mitochondrial ROS output and fibroblast activation. | Binds to ATP5B and shut down mPTP by blocking CypD-mPTP interaction. | [69] |
Lung | IPF | CircANKRD42 | Upregulated in peripheral blood of IPF patients. | Enhanced the mechanical stiffness. Promoted the fibroblasts differentiation, activation and migration, and ECM synthesis. | Directly targets AJUBA and YAP1, through sponging miR-324-5p and miR-136-5p, respectively, and promoted the nuclear translocation of pYAP1, therefore facilitating the transcription of genes related to mechanical stiffness. | [71] |
Lung | IPF | CircTADA2A | Downregulated in IPF fibroblasts. | CircTADA2A decreased fibrogenic responses in vivo and vitro. | Targeting miR-526b/Cav1 and miR-203/Cav2 axes | [72] |
Lung | Bleomycin- induced PF | CircHIPK3 | Upregulated in pulmonary fibrosis. | Silencing circHIPK3 inhibited fibroblast-to-myofibroblast transition and suppressed fibroblasts proliferation. | Targeting miR-338-3p/COL1A1, SOX4, or enhancing glycolysis through miR-30a-3p/FOXK axis. | [75] |
Renal | FAN | CircHIPK3 | Increased in FAN | Promoted the production of profibrotic factors. | Targeting miR-30a and uprelagulating the downstream genes, including FN, TGFb1, COL1. | [81] |
Renal | IRI or toxic kidney diseases | CircBNC2 | Decreased in IRI or toxic kidney injuries | Ectopic circBNC2 mitigated maladaptive fibrotic repair after kidney injury by improving TEC G2/M arrest. | Translating into a 681-amino-acid protein and promoted CDK1/cyclin B1 complex formation and nuclear translocation, and alleviated TEC G2/M arrest. | [84] |
Renal | IRI, UUO and patients with CKD | CircPTPN14 | Increased in RF. | Silencing circPTPN14 alleviated the progression of fbrosis in kidneys subjected to IRI or UUO. | Promoting FUSP1 binding to FUSE, which enhances MYC and related fibrotic genes transcription. | [85] |
Skin | Keloid tissues and keloid fibroblasts | Circ_0057452 | Upregulated in keloid fibroblasts | Knockdown of circ_0057452 inhibited the proliferation, migration, invasion, and collagen synthesis and induced cell cycle arrest and apoptosis of KFs. | MiR-7-5p/GAB1 | [89] |
Skin | Keloid tissues and keloid fibroblasts | CircCOL5A1 | Upregulated in keloid fibroblasts | CircCOL5A1 knockdown repressed the proliferation, migration, ECM deposition and promoted cell apoptosis. | MiR-7-5p/Epac1 | [91] |